Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Etelcalcetide

Brand: Parsabiv ®
NICE TA: 448
Indication: Etelcalcetide for treating secondary hyperparathyroidism (NICE TA448)
Disease category: Endocrine system
Commissioning responsibility: NHSE
PbR excluded: Yes

Background

Etelcalcetide is recommended as an option for treating secondary hyperparathyroidism in adults with chronic kidney disease on haemodialysis, only if:
• treatment with a calcimimetic is indicated but cinacalcet is not suitable and
• the company provides etelcalcetide with the discount agreed in the patient access scheme.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist Medicine

Supporting documents:

NICE TA448 - Etelcalcetide for treating secondary hyperparathyroidism

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red